top of page
ADVOCATE
EDUCATE
MONITOR
MENTOR
Advancing Clinical Research and Clinical Trial Standards in Southern Africa
NEWS & UPDATES
Update on November 2nd New Submissions SAHPRA.
Importance: High Update dated: 1st November: Continued closure of Civitas building and on-going work activities at SAHPRA. Please find in...
Cancellation of all deliveries to SAHPRA for the week ending November 2nd.
Importance: High Deliveries to SAHPRA cancelled this week. The Civitas Building was evacuated and closed earlier today, as such SAHPRA...
Deliveries to SAHPRA week ending November 2nd.
Importance: High Deliveries to SAHPRA this week: Thursday 1st November Time: 13:00 - 14:00 Please take note: Again a plea regarding...
Deliveries to SAHPRA today between 13:00 -14:00: October 24th)
Sent: Tuesday, October 23, 2018 Subject: Importance: High Deliveries to SAHPRA today only for this week: Wednesday 24th Time: 13:00 -...
Submission procedure for all Section 21 Stakeholders
Dear All Find attached revised communication regarding section 21 applications in the link here. There is now a web-based form for new...
SACRA Conference 2018 - a "must attend" event for sites!
The 8th SACRA Clinical Trial Conference is taking place on 27th and 28th September, with a GCP Refresher Course taking place as a...
Contact for submissions 10 - 14 September 2018
Contact for submissions 10 - 14 September 2018 in the event of a continued strike at Civitas Building. Further to the media release of 14...
Comments on Amendment of Fees released August 31st, 2018.
Dear All, Please be advised of a new Fee structure suggested by the Office of the Minister of Health in consultation with the Minister of...
Count down to SACRA's 8th Clinical Trials Conference: 26th -28th September, 2018.
As part of our 8th Annual Clinical Research Conference, SACRA will be hosting a GCP & GCLP Refresher Course, made available to all...
Submissions extended to Wednesday 29th August.
Submission date of new clinical trial applications extended to Wednesday 29th August. Good Day. This serves to inform our clinical trials...
bottom of page